XDNA
Strategic Trust Kelly CRISPR & Gene Editing Technology ETF
XDNA
XDNA
Delisted
XDNA was delisted on the 30th of November, 2023.
3 hedge funds and large institutions have $1.54M invested in Strategic Trust Kelly CRISPR & Gene Editing Technology ETF in 2022 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
3
Holders Change
+1
Holders Change %
+50%
% of All Funds
0.05%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
2
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Jane Street
New York
|
+$870K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$284K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$63.2K |
Top Sellers
No sellers this quarter
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
1
Jane Street
New York
| $1.19M | +$870K | +74,210 | +271% |
|
|
2
Citadel Advisors
Miami,
Florida
| $284K | +$284K | +24,211 | New |
|
|
3
UBS Group
Zurich,
Switzerland
| $65K | +$63.2K | +5,367 | +3,554% |
|